Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 17 Source: CRO
- €674.9 million turnover
-
€41.9 million
profit - 4,407 employees
-
30th Sep 16 Source: CRO
- €507.1 million turnover
-
€30.4 million
profit - 3,975 employees
- 9 more years available »
Ranking
By Turnover
(€674.9 million)- 120th in Top Companies
- 19th in Health
By Employees
(4,407)- 43rd in Top Companies
- 8th in Health
-
- 4,407
- €674.9 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- 5:55am Uber’s e-bike plan for Dublin rejected on safety grounds
- 5:30am Center Parcs set to go wild at ‘subtropical’ Longford resort
- Feb 22 Carbery to extend cheese production into mozzarella
- Feb 22 UBS sticks to dividend, capital return plans after French verdict
- Feb 22 Markets optimistic over US-China trade row breakthrough hopes